Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.

Peter J Goadsby Deborah I FriedmanDagny Holle-LeeGenevieve Demarquay Sait AshinaFumihiko SakaiBrian NeelPranav GandhiBrett DabruzzoJonathan H SmithYingyi LiuJoel M Trugman

Published in: Neurology (2024)

This study provides Class II evidence that atogepant reduces mean MMDs, MHDs, and monthly acute medication use days in adult patients with or without medication overuse.

Keyphrases

double blind
phase iii
liver failure
placebo controlled
phase ii
clinical trial
respiratory failure
drug induced
open label
study protocol
healthcare
aortic dissection
adverse drug
randomized controlled trial
hepatitis b virus
extracorporeal membrane oxygenation
mechanical ventilation